Stanton Hugger
Psychiatric/Mental Health · Fort Myers, FLNPI 1881053437
Payments from drug & device makers
Across 121 payments — averaging $86.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Neurocrine Biosciences, Inc.$529
- Teva Pharmaceuticals USA, Inc.$273
- Johnson & Johnson$268
- Otsuka America Pharmaceutical, Inc.$220
- Tempus AI, Inc$207
- plus $698 from 11 others
What the payments were for
- Speaking & faculty fees$4,50043%
- Travel & lodging$3,00329%
- Food & beverage$2,94528%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $8,261 |
| Neurocrine Biosciences, Inc. | 13 | $529 |
| Teva Pharmaceuticals USA, Inc. | 8 | $273 |
| Johnson & Johnson | 10 | $268 |
| Otsuka America Pharmaceutical, Inc. | 11 | $220 |
| Tempus AI, Inc | 8 | $207 |
| Idorsia Pharmaceuticals US Inc | 5 | $161 |
| E.r. Squibb & Sons, L.L.C. | 2 | $140 |
| Biogen | 1 | $114 |
| Alkermes, Inc. | 5 | $110 |
| Tris Pharma Inc | 2 | $36 |
| Almatica Pharma LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $29 |
| Noven Therapeutics, LLC | 1 | $23 |
| Neos Therapeutics, LP | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,456 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $140,409 |
| Aripiprazole | 35 | $4,294 |
| Doxepin Hcl | 11 | $1,298 |
| Atomoxetine Hcl | 17 | $898 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $648 |
| Divalproex Sodium | 17 | $625 |
| Duloxetine Hcl | 27 | $404 |
| Hydroxyzine Hcl | 23 | $303 |
| Lamotrigine | 22 | $291 |
| Prazosin Hcl | 16 | $266 |
| Quetiapine Fumarate | 25 | $232 |
| Mirtazapine | 11 | $221 |
| Buspirone Hcl | 11 | $196 |
| Topiramate | 11 | $173 |
| Bupropion XlBupropion Hcl | 19 | $143 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $529 | $140,40913 claims |
| Almatica Pharma LLCSertraline Hcl | $35 | $2711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Fort Myers
- Dylan DemarsFort Myers$24K
- Jacqueline BannisterFort Myers$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.